| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $129K | +59.3% |
| SG&A Expense | $2.0M | +219.1% |
| Operating Income | -$2.2M | -201.1% |
| Net Income | -$1.3M | +59.0% |
| EPS (Basic) | -$0.01 | +80.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60K | -70.9% |
| Current Assets | $79K | -77.8% |
| Total Assets | $205K | -59.5% |
| Current Liabilities | $2.8M | +9.8% |
| Total Liabilities | $2.8M | -5.7% |
| Stockholders' Equity | -$2.5M | -5.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$595K | -254.2% |
| Capital Expenditures | $3K | +0.0% |
| Investing Cash Flow | $167K | +0.0% |
| Financing Cash Flow | $442K | +125.5% |
| Free Cash Flow | -$598K | -249.7% |